Proteins from the kallikrein family could mediate cancer progression through multiple signaling pathways, including the PAR (protease-activated receptors) signaling pathway, the IGF (insulin like growth factor) signaling pathway, the kallikrein signaling pathway, and the steroid hormone signaling pathway [8]. Here, KLK4 is linked to cancer.